Biotechnology News

July 26, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hyperion Therapeutics, Inc. (NASDAQ:HPTX) announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at $10.00 per share, before underwriting discounts and...

July 26, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Lymphoseek® Data Presented by Independent Investigators at 8th International Conference on Head and Neck Cancer in July 2012

July 26, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends surveyed 83 nephrologists about their current awareness, trial and usage of Affymax/Takeda’s Omontys, an ESA recently approved by the FDA

July 26, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--The number of diagnosed incident cases of NSCLC in urban China will increase five percent annually between 2011 and 2016, according to a new report from Decision Resources.

July 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Proteostasis Therapeutics announced today that it has expanded its collaboration with The Scripps Research Institute (TSRI) to encompass an additional research project focused on cystic fibrosis.

July 26, 2012

CLEVELAND--(BUSINESS WIRE)--ImageIQ partners with Histogenics to manage NeoCart Phase 3 Clinical Trial.

July 26, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) reported total revenue of $1,367 million for the second quarter of 2012, a 16 percent increase from the same period in 2011. Non-GAAP net income for the second quarter of 2012...

July 26, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta (NASDAQ: SNTA) entered into common stock subscription agreements with members of its Board of Directors for the sale of 3,976,702 shares at $6.49 per share, for gross proceeds of $25.8 million.

July 26, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company's second quarter 2012 financial results on Wednesday, August 8 at 9:00...

July 26, 2012

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO): GENERAL HIGHLIGHTS Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today: reported fiscal 2012 third quarter and nine months net sales of $42.1 million and $129.8...

July 26, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals announces publication of positive long-term clinical data for ZEVALIN® (ibritumomab tiuxetan) Injection in patients with advanced, relapsed follicular non-Hodgkin’s lymphoma.

July 26, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (NASDAQ:BABY) today announced financial results for the three and six months ended June 30, 2012. For the second quarter ended June 30, 2012, the Company reported revenue of $61.0...

July 26, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for its first quarter of fiscal 2013, which ended June 30, 2012, and reiterated expectations for its fiscal year 2013, which will be the first full fiscal year...

July 26, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and...

July 26, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a specialty pharmaceutical company focused on the development and commercialization of Feraheme® (ferumoxytol) Injection for intravenous (IV) use to treat iron...

July 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology Announces Timing for Second Quarter Financial Results, Webcast and Conference Call

July 26, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced the initiation of two investigator-sponsored trials (ISTs) of cabozantinib, which simultaneously targets MET, VEGFR2 and RET. Naiyer Rizvi, M.D., a lung...

July 26, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics Announces Second Quarter 2012 Financial Results; 2012 Revenue Guidance Increased; Live Conference call at 9am - www....

July 26, 2012

HEIDELBERG, Germany--(BUSINESS WIRE)--The biopharmaceutical company Apogenix GmbH announced today that the phase II clinical proof of concept trial with APG101 as treatment of recurrent glioblastoma has met and exceeded expectations in the final...

July 26, 2012

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: The Board of Directors of DBV Technologies (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, chaired by Pierre-Henri Benhamou met on July 25,...

July 26, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today the pricing of an underwritten offering of 6,153,846 shares of its common stock at a price to the public of $6.50 per share. XenoPort has granted to the...

July 26, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Sequella, a clinical-stage pharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, licensed the late-stage development and commercialization of its lead...

July 25, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its third...

July 25, 2012

FRISCO, Texas--(BUSINESS WIRE)--Greatbatch, Inc. (NYSE: GB), today announced results for its second quarter ended June 29, 2012: Sales increased 14% over the prior year to a record $166.5 million, and included the following: $21.3 million of...

July 25, 2012

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today announced that its Lutonix technology center completed patient enrollment into its global, multicenter LEVANT 2 randomized clinical trial (...

July 25, 2012

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today reported 2012 second quarter financial results. Second quarter 2012 net sales were $742.6 million, an increase of 2 percent over the prior-year period on a reported basis....

July 25, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it intends to offer and sell shares of its common stock, subject to market and other conditions, in an underwritten public offering. All of the shares in the...

July 25, 2012

WASHINGTON--(BUSINESS WIRE)--Over 1,000 IP, licensing, business development and technology law professionals will attend the LES (USA & Canada) Annual Meeting, October 14-17 in Toronto. Visit...

July 25, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has begun enrolling patients into the fourth...

July 25, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report second quarter 2012 financial results on Wednesday, August 8, 2012. Ligand’s President and CEO, John L. Higgins, Executive Vice...

July 25, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that novel emerging agents will experience rapid uptake owing to the high...

July 25, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier healthcare alliance names Durral Gilbert president of supply chain services

July 25, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today the commencement of a tender offer (“Tender Offer”) to purchase for cash up to $500 million of its outstanding 10⅜/11⅛% Senior Toggle Notes due 2017 (CUSIP Nos. 090613AD2, 550785AC3 and...

July 25, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast:       What: Transgenomic, Inc. Second Quarter 2012 Financial Results and Business Update Conference Call   When: Wednesday, August 1, 2012 @ 5:...

July 25, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information is pleased to announce a comprehensive set of metrics designed for medical affairs teams looking to arm their MSL programs with key performance indicators and benchmarks.

July 25, 2012

NEW YORK--(BUSINESS WIRE)--Pharmaceutical companies aggressively investing in high-growth markets are looking to leverage the digital channel to augment their sales and marketing efforts. In response to these trends, healthcare market research...

July 25, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical today announced general availability of the Aprima Access Nonvascular Introducer Set, the first product in the Aprima drainage portfolio.

July 25, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--New SEEDS supplier added to Premier’s blood pressure cuffs and accessories portfolio

July 25, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Pharmaceutical market research teams find that qualitative studies are cost-effective and may deliver the same results as quantitative studies.

July 25, 2012

LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma symposium on challenges of von Willebrand Disease diagnosis and treatment. wilate® is a high-purity von Willebrand/Factor VIII preparation therapy with VWF and FVIII in physiological 1:1

July 25, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 1b clinical trial to determine the maximum tolerated dose and to evaluate preliminary...

July 25, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma announced that it has entered into definitive agreements with certain new and existing institutional investors relating to a private placement of common stock.

July 25, 2012

SEND, England--(BUSINESS WIRE)--Anaxsys files a 510(k) Premarket Notification with the U.S. Food and Drug Administration (FDA) respiR8 continuous respiratory rate counter.

July 25, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that recognized food industry experts Dave Pfanzelter and David Theno, Jr., Ph.D. have joined...

July 25, 2012

PERKASIE, Pa.--(BUSINESS WIRE)--Secant Medical® announced today that it has received industry analyst Frost & Sullivan’s 2012 North American Enabling Technology Award for its medical implantable textile structures design approach.

July 25, 2012

SAN DIEGO--(BUSINESS WIRE)--bioTheranostics, Inc., today announced that Mary Jo Mullen, chief commercial officer, and Isaac J. Bright, MD, vice president, corporate development, have joined the company’s senior management team.

July 25, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics (NYSE MKT: IMUC) today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase...

July 25, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter ended June 30, 2012.

July 25, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb’s Second Quarter Highlighted by the Planned Strategic Acquisition of Amylin Pharmaceuticals and Important Clinical Data in Immuno-Oncology